340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Studies Lift Lid on Drug Industry Influence Peddling


 

Print Article

January 18, 2017—Patient advocacy groups and private practice oncologists frequently parrot the drug industry about the 340B drug discount program. New research in JAMA Internal Medicine sheds light on why that might be. [ms-protect-content id=”2799″]

A national survey found that two out of three patient advocacy groups get funding from for-profit companies, with the largest share coming from the drug industry. A second study found that nearly four out of five U.S. hematologist-oncologists who use Twitter have financial conflicts of interest.

“The very way we all think about disease—and the best ways to research, define, prevent, and treat it—is being subtly distorted because so many of the ostensibly independent players, including patient advocacy groups, are largely singing tunes acceptable to companies seeking to maximize markets for drugs and devices,” researchers Ray Moynihan and Lisa Bero wrote in an accompanying commentary in the medical journal.

The survey of patient advocacy groups found that 12 percent got more than half of their funding from industry. Overall, 45 percent of the groups’ industry funding came from the pharmaceutical, medical device, and/or biotechnology sectors.

The second study found that 44.3 percent of hematologist-oncologists on Twitter got more than $1,000 in consulting fees, travel, lodging, food, and drinks from the drug and/or medical device industries. The researchers recommended that, at a minimum, physicians on Twitter should disclose their industry funding in their Twitter user biographies.

Finding ties to the drug industry often isn’t hard. A quick search of an advocacy group’s corporate sponsors can be illuminating.

Register – 340B Coalition Winter Conference – February 1-3, 2017 – San Francisco, Calif. [/ms-protect-content]

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
4h

There’s a lot of misinformation out there about the #340B drug pricing program. Let’s clear things up🧵⬇️

Reply on Twitter 1976320035644899526 Retweet on Twitter 1976320035644899526 Like on Twitter 1976320035644899526 1 Twitter 1976320035644899526
340bhealth 340B Health @340bhealth ·
8 Oct

Fifteen years ago, Hanan Tadros struggled to manage multiple chronic conditions & prescriptions. Thanks to @UIHealth’s #340B-supported medication therapy management clinic, she now manages her health at no out-of-pocket cost and hasn’t needed insulin for 7 years. Hear her story:…

Reply on Twitter 1975988312138490364 Retweet on Twitter 1975988312138490364 Like on Twitter 1975988312138490364 Twitter 1975988312138490364
340bhealth 340B Health @340bhealth ·
7 Oct

What is the 340B program, and why does it matter for patients and communities? Let’s break it down. 🧵

Reply on Twitter 1975619321562055069 Retweet on Twitter 1975619321562055069 Like on Twitter 1975619321562055069 Twitter 1975619321562055069
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health